TY - JOUR AU - Innes, H. AU - Lim, S. L. AU - Hall, A. AU - Chan, S. Y. AU - Bhalla, N. AU - Marshall, E. PY - 2008 DA - 2008// TI - Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice JO - Support Care Cancer VL - 16 UR - https://doi.org/10.1007/s00520-007-0334-8 DO - 10.1007/s00520-007-0334-8 ID - Innes2008 ER - TY - JOUR AU - Flowers, C. R. AU - Seidenfeld, J. AU - Bow, E. J. AU - Karten, C. AU - Gleason, C. AU - Hawley, D. K. PY - 2013 DA - 2013// TI - Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.45.8661 DO - 10.1200/JCO.2012.45.8661 ID - Flowers2013 ER - TY - JOUR AU - Santolaya, M. E. AU - Alvarez, A. M. AU - Aviles, C. L. AU - Becker, A. AU - Cofre, J. AU - Cumsille, M. A. PY - 2004 DA - 2004// TI - Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.01.078 DO - 10.1200/JCO.2004.01.078 ID - Santolaya2004 ER - TY - JOUR AU - Cullen, M. H. AU - Billingham, L. J. AU - Gaunt, C. H. AU - Steven, N. M. PY - 2007 DA - 2007// TI - Rational selection of patients for antibacterial prophylaxis after chemotherapy JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.08.7395 DO - 10.1200/JCO.2006.08.7395 ID - Cullen2007 ER - TY - JOUR AU - Kern, W. V. AU - Marchetti, O. AU - Drgona, L. AU - Akan, H. AU - Aoun, M. AU - Akova, M. PY - 2013 DA - 2013// TI - Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial X JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.45.8109 DO - 10.1200/JCO.2012.45.8109 ID - Kern2013 ER - TY - JOUR AU - Klastersky, J. AU - Paesmans, M. AU - Georgala, A. AU - Muanza, F. AU - Plehiers, B. AU - Dubreucq, L. PY - 2006 DA - 2006// TI - Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.03.9909 DO - 10.1200/JCO.2005.03.9909 ID - Klastersky2006 ER - TY - JOUR AU - Rolston, K. V. AU - Manzullo, E. F. AU - Elting, L. S. AU - Frisbee-Hume, S. E. AU - McMahon, L. AU - Theriault, R. L. PY - 2006 DA - 2006// TI - Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules JO - Cancer VL - 106 UR - https://doi.org/10.1002/cncr.21908 DO - 10.1002/cncr.21908 ID - Rolston2006 ER - TY - JOUR AU - Sung, L. AU - Feldman, B. M. AU - Schwamborn, G. AU - Paczesny, D. AU - Cochrane, A. AU - Greenberg, M. L. PY - 2004 DA - 2004// TI - Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents’ and healthcare professionals’ preferences JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.01.077 DO - 10.1200/JCO.2004.01.077 ID - Sung2004 ER - TY - JOUR AU - Elting, L. S. AU - Lu, C. AU - Escalante, C. P. AU - Giordano, S. H. AU - Trent, J. C. AU - Cooksley, C. PY - 2008 DA - 2008// TI - Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.13.8222 DO - 10.1200/JCO.2007.13.8222 ID - Elting2008 ER - TY - JOUR AU - Freifeld, A. AU - Marchigiani, D. AU - Walsh, T. AU - Chanock, S. AU - Lewis, L. AU - Hiemenz, J. PY - 1999 DA - 1999// TI - A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy JO - N Engl J Med VL - 341 UR - https://doi.org/10.1056/NEJM199907293410501 DO - 10.1056/NEJM199907293410501 ID - Freifeld1999 ER - TY - JOUR AU - Patel, J. D. AU - Galsky, M. D. AU - Chagpar, A. B. AU - Pyle, D. AU - Loehrer, P. J. PY - 2011 DA - 2011// TI - Role of American Society of Clinical Oncology in low- and middle-income countries JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2011.35.6378 DO - 10.1200/JCO.2011.35.6378 ID - Patel2011 ER - TY - JOUR AU - Talcott, J. A. AU - Yeap, B. Y. AU - Clark, J. A. AU - Siegel, R. D. AU - Loggers, E. T. AU - Lu, C. PY - 2011 DA - 2011// TI - Safety of early discharge for low-risk patients with febrile neutropenia: a multicenter randomized controlled trial JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2011.35.0884 DO - 10.1200/JCO.2011.35.0884 ID - Talcott2011 ER - TY - JOUR AU - Wang, J. PY - 2010 DA - 2010// TI - Evidence-based medicine in China JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(09)62131-0 DO - 10.1016/S0140-6736(09)62131-0 ID - Wang2010 ER - TY - JOUR AU - Heddini, A. AU - Cars, O. AU - Qiang, S. AU - Tomson, G. PY - 2009 DA - 2009// TI - Antibiotic resistance in China–a major future challenge JO - Lancet VL - 373 UR - https://doi.org/10.1016/S0140-6736(08)61956-X DO - 10.1016/S0140-6736(08)61956-X ID - Heddini2009 ER - TY - JOUR AU - Wang, L. AU - Wang, Y. AU - Jin, S. AU - Wu, Z. AU - Chin, D. P. AU - Koplan, J. P. PY - 2008 DA - 2008// TI - Emergence and control of infectious diseases in China JO - Lancet VL - 372 UR - https://doi.org/10.1016/S0140-6736(08)61365-3 DO - 10.1016/S0140-6736(08)61365-3 ID - Wang2008 ER - TY - JOUR AU - Radyowijati, A. AU - Haak, H. PY - 2003 DA - 2003// TI - Improving antibiotic use in low-income countries: an overview of evidence on determinants JO - Soc Sci Med VL - 57 UR - https://doi.org/10.1016/S0277-9536(02)00422-7 DO - 10.1016/S0277-9536(02)00422-7 ID - Radyowijati2003 ER - TY - JOUR AU - Castagnola, E. AU - Haupt, R. AU - Micozzi, A. AU - Caviglia, I. AU - Testi, A. M. AU - Giona, F. PY - 2005 DA - 2005// TI - Differences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two Italian centres JO - Clin Microbiol Infect VL - 11 UR - https://doi.org/10.1111/j.1469-0691.2005.01114.x DO - 10.1111/j.1469-0691.2005.01114.x ID - Castagnola2005 ER - TY - JOUR AU - Cattaneo, C. AU - Quaresmini, G. AU - Casari, S. AU - Capucci, M. A. AU - Micheletti, M. AU - Borlenghi, E. PY - 2008 DA - 2008// TI - Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution JO - J Antimicrob Chemother VL - 61 UR - https://doi.org/10.1093/jac/dkm514 DO - 10.1093/jac/dkm514 ID - Cattaneo2008 ER - TY - JOUR AU - Cometta, A. AU - Marchetti, O. AU - Calandra, T. AU - Bille, J. AU - Kern, W. V. AU - Zinner, S. PY - 2006 DA - 2006// TI - In vitro antimicrobial activity of moxifloxacin against bacterial strains isolated from blood of neutropenic cancer patients JO - Eur J Clin Microbiol Infect Dis VL - 25 UR - https://doi.org/10.1007/s10096-006-0175-2 DO - 10.1007/s10096-006-0175-2 ID - Cometta2006 ER - TY - JOUR AU - Zaidi, Y. AU - Hastings, M. AU - Murray, J. AU - Hassan, R. AU - Kurshid, M. AU - Mahendra, P. PY - 2001 DA - 2001// TI - Quinolone resistance in neutropenic patients: the effect of prescribing policy in the UK and Pakistan JO - Clin Lab Haematol VL - 23 UR - https://doi.org/10.1046/j.1365-2257.2001.00347.x DO - 10.1046/j.1365-2257.2001.00347.x ID - Zaidi2001 ER - TY - JOUR AU - Zemkova, M. AU - Kotlarova, J. AU - Merka, V. AU - Cermak, P. AU - Vlcek, J. AU - Jebavy, L. PY - 2007 DA - 2007// TI - Emergence of fluoroquinolone resistance in Escherichia coli isolates at the department of clinical hematology JO - New Microbiol VL - 30 ID - Zemkova2007 ER - TY - JOUR AU - Timmer-Bonte, J. N. AU - Boo, T. M. AU - Smit, H. J. AU - Biesma, B. AU - Wilschut, F. A. AU - Cheragwandi, S. A. PY - 2005 DA - 2005// TI - Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2004.00.7955 DO - 10.1200/JCO.2004.00.7955 ID - Timmer-Bonte2005 ER - TY - JOUR AU - Ammann, R. A. AU - Bodmer, N. AU - Hirt, A. AU - Niggli, F. K. AU - Nadal, D. AU - Simon, A. PY - 2010 DA - 2010// TI - Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.25.8988 DO - 10.1200/JCO.2009.25.8988 ID - Ammann2010 ER - TY - JOUR AU - Zhang, R. AU - Eggleston, K. AU - Rotimi, V. AU - Zeckhauser, R. J. PY - 2006 DA - 2006// TI - Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States JO - Global Health VL - 2 UR - https://doi.org/10.1186/1744-8603-2-6 DO - 10.1186/1744-8603-2-6 ID - Zhang2006 ER - TY - JOUR AU - He, L. AU - Zhou, C. AU - Zhao, S. AU - Weng, H. AU - Yang, G. PY - 2015 DA - 2015// TI - Once-daily, oral levofloxacin monotherapy for low-risk neutropenic fever in cancer patients: a pilot study in China JO - Anticancer Drugs VL - 26 UR - https://doi.org/10.1097/CAD.0000000000000187 DO - 10.1097/CAD.0000000000000187 ID - He2015 ER -